1Van Dyek E, Karita E, Abdellati S, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda, and trends of resistance between 1986 and 2000. Sex Transm Dis 2001,28:539-545.
2WHO Westem Pacific Region Gonococcal Antimicrobial Surveillance programme. Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treat of gonorrhoeae 1997. Commun Dis Int 1998,13:288-291.
3Clandnnen TE, Echeverria P, Saenguer S, et al. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother 1992,36:1682 - 1687.
4Kam KM,Lo KK,Ho NKY,et al.Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4 - fluoroquinolone resistance. Genitourin Med 1995,71 : 141 -144.
5Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region. Commun Dis Int 2002,26:541 - 545.
6Tanaka M, Nakayama H, Notomi T, et al. Antimicrobial of Neisseria gonorrhoeae in Japan, 1993 - 2002: continuous increasing of cipro-floxacin- resistant isolates. Int J Antimicrob Agents 2004,24:15 -22.
7Ray K, Bala M, Kumari S, et al. Antimicrobial resistance of Neisseria gonorrhoeae in selected World Health Organization Southeast Asia Region countries: an overview. Sex Transm Dis 2005,32:178 - 184.
8CDC. Sexually transmitted disease surveillance supplement: gonocacal isolate surveillance program (GISP) annual report - 2001. Atlanta Georgia: U.S. Department of Health and Human Service, 2002.10.
9Akasaka S, Muratani T, Yamada Y, et al. Emergence of cephem and aztreonam- high - resistant Neisseria gonorrhoeae that does not produce beta- latamese. J Infect Chemother 2001,7:49 - 50.
10Akasaka S, Muratani T, Kobayashi T, et al. Gonococcal urethritis and cervicitis caused by CARNG (cefozopran- resistant Neisseria gonorrhoeae) - clinical failure of cases treated with expanded spectrum cephems, fluoroquinoloes and minocycline. Abstrct 327. Thirteenth International Pathogenic Neisseria Conference, Oslo Norway,2002.
4Gransden WR,Warren CA,Phillips I,et al.Decreased susceptibilityof Neisseria gonorrhoeae to ciprofloxacin.Lancet,1990,335:51.
5Schwebke JR,Whittington W,Rice R J,et al.Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991.Antimicrob Agents Chemother,1995,39:917-920.
6Belland RJ,Morrison SG,Ison C,et al.Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.Mol Microbiol,1994,14:371-380.
7Tanaka M,Fukuda H,Hirai K,et al.Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.Genitourin Med,1994,70:253-255.
8叶顺章,张木有.现代性传播疾病实验诊断技术.广州:广东科技出版社,1999.25-38.
9World Health Organization. Sensitivity testing of Neisseria gonorrhoeae: methodologies for use by participants in the WHO Western Pacific Regional Surveillance Programme. In: WHO/WPR Regional Antimicrobial Surevillance Working Group Meeting Proceedings,1992.
10No authors listed. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. World Health Organization. Commun Dis Intell, 2002, 26:541-545.
